Markup of H.R. 4299, "Improving Regulatory Transparency for New Medical Therapies Act," H.R. 4709, "Ensuring Patient Access and Effective Drug Enforcement Act," and H.R. 4631, "Combating Autism Reauthorization Act," Subcommittee on Health (May 28, 2014)
Subcommittee on Health (113th Congress)
May 28, 2014
2123 Rayburn House Office Building
The Subcommittee on Health held a markup on Wednesday, May 28, 2014, at 2:00 p.m. in 2123 Rayburn House Office Building. The Subcommittee considered the following bills:
Documents
Memorandum from Ranking Member Henry A. Waxman to Democratic Members of the Subcommittee on Health
H.R. 4299, “Improving Regulatory Transparency for New Medical Therapies Act,” favorably forwarded by voice vote.
H.R. 4709, “Ensuring Patient Access and Effective Drug Enforcement Act," favorably forwarded by voice vote.
H.R. 4631, “Combating Autism Reauthorization Act of 2014,” favorably forwarded, as amended, by voice vote.
Amendment by Rep. Pitts, passed by voice vote.
Webcast
Key Documents:
Bills:
113th Congress
Recent News
- 1 of 101
- ››